Last update 01 Nov 2024
Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.

Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.

Company|
2006|
Shanghai Shi, China

Overview

Related

1
Drugs associated with Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.
Eliglustat
Target
UGCG
Mechanism
UGCG inhibitors
Active Org.
SanofiSanofi [+4]
Originator Org.
Genzyme Corp.Genzyme Corp.
Active Indication
Gaucher Disease [+2]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date19 Aug 2014
1
Clinical Trials associated with Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.
CTR20140075 / CompletedPhase 3
比较每日两次和一次口服Genz-112638治疗对已接受每日两次治疗达到临床稳定的I型戈谢病患者影响的III期临床研究
[Translation] Phase III study comparing twice-daily versus once-daily oral Genz-112638 in patients with type 1 Gaucher disease who have achieved clinical stability on twice-daily therapy
100 Clinical Results associated with Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.
Login to view more data
100 Deals associated with Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.
Login to view more data
100 Translational Medicine associated with Genzyme (Shanghai) Biopharmaceutical Service Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Eliglustat
 ( UGCG )		Gaucher Disease, Type 1
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free